Back to search
Cyanotic Heart Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cyanotic Heart Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cyanotic Heart Disease trials you may qualify forThis prospective cohort study evaluates differences in clinical outcomes between pulmonary oligemia and pulmonary plethora in patients with cyanotic congenital…
Congenital heart disease (CHD) is the leading cause of congenital malformations, representing 1% of live births. Progress in surgical care have led to the drama…
The goal of this study is to evaluate the effects of steroids on the early postoperative inflammatory response in patients undergoing elective pediatric congeni…
Congenital heart disease can lead to serious health issues, particularly an increased risk of infections, specifically respiratory infections. Lower respiratory…
Multi-detector computed tomography angiography (MDCTA) provides high-resolution images of the heart and its vasculature, allowing for accurate anatomical assess…
Respiratory diseases are associated with high morbidity and mortality worldwide. Proper diagnosis and risk assessment of these conditions are essential for opti…